📖
Development of Fragment-Based Inhibitors of the Bacterial Deacetylase LpxC with Low Nanomolar Activity
Sebastian Mielniczuk, Katharina Hoff, Fady Baselious, Yunqi Li, Jörg Haupenthal, Andreas M Kany, Maria Riedner, Holger Rohde, Katharina Rox, Anna K H Hirsch, Isabelle Krimm, Wolfgang Sippl, Ralph Holl

Development of Fragment-Based Inhibitors of the Bacterial Deacetylase LpxC with Low Nanomolar Activity

Science & Mathematics Published 2024 Verification Pending

Overview & Synopsis

In a fragment-based approach using NMR spectroscopy, benzyloxyacetohydroxamic acid-derived inhibitors of the bacterial deacetylase LpxC bearing a substituent to target the uridine diphosphate-binding site of the enzyme were developed. By appending privileged fragments via a suitable linker, potent LpxC inhibitors with promising antibacterial activities could be obtained, like the one-digit nanomolar LpxC inhibitor (S)-13j [K i (EcLpxC C63A) = 9.5 nM; K i (PaLpxC): 5.6 nM]. To rationalize the observed structure-activity relationships, molecular docking and molecular dynamics studies were performed. Initial in vitro absorption-distribution-metabolism-excretion-toxicity (ADMET) studies of the most potent compounds have paved the way for multiparameter optimization of our newly developed isoserine-based amides. f1 uridine diphosphate (UDP)-3-O-[(R)-3-hydroxymyristoyl]-N-47 f1 acetylglucosamine (1, Figure 1A), is considered as the 48 committed step of lipid A biosynthesis. 11 This step is catalyzed 49 by the Zn 2+ -dependent deacetylase LpxC. The enzyme is 50 present in virtually all Gram-negative bacteria, is highly 51 conserved among them, and possesses no mammalian 52 counterpart, which makes LpxC an excellent target for the 53 development of novel antibiotics. 12 54 Structural studies revealed that LpxC displays a "β-α-α-β 55 sandwich" fold, being formed by two domains with similar 56 topologies. 14 The catalytic Zn 2+ -ion is complexed by one 57 aspartate and two histidine residues at the bottom of a conical 58 active-site cleft, which is located at one side of the sandwich at 59 the interface of the two domains (Figure 1B). 15 A hydrophobic 60 tunnel leads out of the active-site pocket, which binds the 3-O-61 [(R)-3-hydroxyacyl] substituent of the enzyme's natural 62 substrate 1 during catalysis. 16 63 Hitherto, various structural classes of small-molecule LpxC 64 inhibitors have been described. 22-27 Like the N-aroyl-L-65 threonine derivatives CHIR-090 (Figure S1) and LPC-011 66 f2(3a, Figure 2), 16,28 most of these inhibitors exhibit a Zn 2+ -

Indexed from repository: HAL Open Science (hal.science)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title Development of Fragment-Based Inhibitors of the Bacterial Deacetylase LpxC with Low Nanomolar Activity
Author / Organization Sebastian Mielniczuk, Katharina Hoff, Fady Baselious, Yunqi Li, Jörg Haupenthal, Andreas M Kany, Maria Riedner, Holger Rohde, Katharina Rox, Anna K H Hirsch, Isabelle Krimm, Wolfgang Sippl, Ralph Holl
Subject & Discipline Multidisciplinary Academic Open Research
Categories Science & Mathematics
Publication Year 2024
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website HAL Open Science (hal.science)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-216811
Original Source Link Visit Source Page on hal.science »